Using decellularized small-diameter vascular bypass substitutes (<6 mm) is an efficient method for bypass grafting. A solution containing 0.5% SDS (weight/volume) is commonly used for extended periods to generate acellular tissues. However, this solution causes damage to the microfibril structure and alters the mechanical forces. Hence, the objective of this study is to reduce the concentration of SDS to preserve the structure and achieve efficient decellularization. The study employs a diluted solution of 0.3% SDS (weight/volume) to treat fresh and frozen swine small-diameter arteries, utilizing physical methods such as freezing and thawing. The effectiveness of cell removal was evaluated using histological analysis and the remaining DNA content of the sample. Furthermore, the acellular circuit also assesses the cytotoxicity and proliferation of HUVECs to gauge their safety. Through the use of 0.3% SDS, a bioreactor system, and freezing-thawing, the pig arteries are successfully decellularized, resulting in residual DNA levels of less than 50 ng/mg dry weight. This process does not cause any major changes to the biomechanical or structural properties of the arteries. The acellular samples exhibit no toxicity on the L929 cell line and promote the growth of HUVECs at their highest rate on the fourth day. This allows for the placement of acellular vascular grafts to evaluate physiological processes within the animal body. This is an important requirement in clinical blood vessel transplantation.
In vitro tumor models that are 3-dimensional (3D) have emerged as a significant area in the field of cancer research over the past several years. In order for breast cancer cell lines to grow and develop, it is important to select a scaffold, determine a strategy for seeding cells into the scaffold, then cultivate the cells under a variety of conditions. Therefore, we cultivated MCF-7 cells and fibroblasts on a gelatin-alginate scaffold alone or in co-culture under static or dynamic culture conditions in order to produce a 3D tumor model. MCF-7 and fibroblast were seeded into Gellatin-Alginate by Centrifugation and Incubation. After that, the cell proliferation was examined by MTT assay and the cell number determination in the scaffold. The morphology of MCF-7 was observed by H&E staining and SEM. The results showed that the co-culture of MCF-7 cells and fibroblasts in the scaffold exhibited an increase in cell mass size. Their mass morphologies feature a significant number of MCF-7 cells with a round structure that persists for an extended period of time. Perfusion bioreactors also demonstrate an increase in the size of cell mass (3 times higher than static culture). As a result, the long-term stability of the structure offers the possibility of cancer biology research and drug testing, especially the sustained release or actions experiements. HIGHLIGHTS This research focuses on aspects of the tissue engineering concept that support the proliferation and development of specific structures within the mass. By experimenting, we were able; GRAPHICAL ABSTRACT
Incorporation of extracellular matrix (ECM) components into bioinks can enhance biological functionality but often compromises print fidelity and structural stability. This study developed a dual-stage calcium chloride (CaCl2) crosslinking strategy to incorporate Wharton’s jelly-derived ECM (WJ-ECM) into a gelatin-alginate bioink for bioprinted scaffold fabrication. A baseline formulation (BGA) and a WJ-ECM-supplemented formulation (BGAE, 1 mg/mL) were pre-crosslinked with 14 mM CaCl2 prior to extrusion, followed by secondary crosslinking in 0.5 M CaCl2 post-printing. Both formulations exhibited comparable viscosity (20–180 kcP) and high print fidelity (Pr = 0.99 ± 0.01 for BGA; 0.95 ± 0.01 for BGAE), with scaffolds displaying well-defined architecture and over 84% of pores within the target range (160–270 µm). FTIR analysis confirmed WJ-ECM incorporation without detectable alteration of the primary matrix structure. Both scaffolds were non-cytotoxic and supported fibroblast viability; BGAE constructs showed greater cell coverage over 14 days when surface-seeded and more stable fluorescence intensity through 28 days when encapsulated. In a murine thermal burn model, BGAE-treated wounds demonstrated more advanced re-epithelialization and more continuous epidermal coverage at day 14 compared to controls. These findings indicate that dual-stage crosslinking enables WJ-ECM integration while preserving printability, offering a practical platform for bioactive skin tissue engineering applications.
This study was carried out to successfully fabricate hydrogel from decellularized amniotic extracellular matrix (ECM) powder. The pre-gel sample form ECM powder was prepared by pepsin digestion and neutralization process. Hydrogel formation was initiated by incubation at physiological temperature. The inversion test determined that 24-hour dissolving in pepsin solution was optimal for the hydrogel fabrication. Histology examination revealed a three-dimensional fibrin network composed of randomly linked fibers. The hydrogel sample retained its shape in PBS 1X solution. In vitro cytotoxicity showed that the hydrogel liquid extract was safe to the cultured fibroblasts. After 24 hour subcutaneuos injection, pre-gel sample was capable of self-assembling and form hydrogel network under in vivo physiological conditio, indicating the potential application to accommodate irregular defects.